Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

2020 Science 1,291 citations

Abstract

Immune profiling of COVID-19 patients Coronavirus disease 2019 (COVID-19) has affected millions of people globally, yet how the human immune system responds to and influences COVID-19 severity remains unclear. Mathew et al. present a comprehensive atlas of immune modulation associated with COVID-19. They performed high-dimensional flow cytometry of hospitalized COVID-19 patients and found three prominent and distinct immunotypes that are related to disease severity and clinical parameters. Arunachalam et al. report a systems biology approach to assess the immune system of COVID-19 patients with mild-to-severe disease. These studies provide a compendium of immune cell information and roadmaps for potential therapeutic interventions. Science , this issue p. eabc8511 , p. 1210

Keywords

Coronavirus disease 2019 (COVID-19)ImmunitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyBetacoronavirusBiologyImmunologyMedicineImmune systemInternal medicineInfectious disease (medical specialty)OutbreakDisease

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
article
Volume
369
Issue
6508
Pages
1210-1220
Citations
1291
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1291
OpenAlex

Cite This

Prabhu S. Arunachalam, Florian Wimmers, Chris Ka Pun Mok et al. (2020). Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science , 369 (6508) , 1210-1220. https://doi.org/10.1126/science.abc6261

Identifiers

DOI
10.1126/science.abc6261